Christopher Chavez

Company: Visgenx Inc.

Job title: Vice President & Head of Synthetic Biology Research & Development

Seminars:

Innovative Non-Viral Gene Editing: Harnessing Synthetic AAV Constructs 9:30 am

Explore how synthetic AAV genomes offer a novel approach to gene editing, providing a versatile platform for precise genetic modifications Discuss the potential of synthetic AAV constructs as efficient non-viral gene delivery vehicles, circumventing limitations associated with traditional viral vectors Uncover preclinical data for a non-CRISPR alternative to gene editing, paving the way for innovative…Read more

day: Day One 11th